{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:54:17Z","timestamp":1769302457713,"version":"3.49.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) study is a nationwide longitudinal antibiotic resistance surveillance program specific to bacterial pathogens commonly encountered in ocular infections. We evaluated in vitro resistance rates and trends among isolates obtained from pediatric patients (\u226417 years of age).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Clinical centers across the United States were invited to submit ocular isolates of<jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>, coagulase-negative staphylococci (CoNS),<jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>,<jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>and<jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>to a central laboratory. Minimum inhibitory concentrations for various antibiotic classes were determined by broth microdilution per Clinical and Laboratory Standards Institute guidelines and interpreted as susceptible, intermediate or resistant based on available breakpoints. Longitudinal trends were analyzed using a Cochran-Armitage test for linear trends in a proportion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Of 4829 isolates collected from January 2009 to December 2016, 995 isolates, sourced primarily from hospitals and referral centers, were obtained from pediatric patients (n = 286<jats:italic toggle=\"yes\">H<\/jats:italic>.<jats:italic toggle=\"yes\">influenzae<\/jats:italic>, n = 284<jats:italic toggle=\"yes\">S<\/jats:italic>.<jats:italic toggle=\"yes\">aureus<\/jats:italic>, n = 213 CoNS, n = 150<jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>and n = 62<jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>). With few exceptions,<jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>and<jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>were generally susceptible to the antibiotics tested. Of<jats:italic toggle=\"yes\">S. aureus<\/jats:italic>and CoNS isolates, respectively, 56% and 72% were resistant to azithromycin and 24% and 47% were methicillin-resistant (MR); concurrent resistance to other drug classes and multidrug resistance (\u22653 drug classes) were prevalent among MR staphylococci. Of<jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>isolates, 38% and 35% demonstrated resistance to azithromycin and penicillin, respectively. Besifloxacin had the lowest minimum inhibitory concentration against the Gram-positive isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>These in vitro data suggest antibiotic resistance is common among staphylococcal and pneumococcal isolates collected from pediatric patients with ocular infections. Methicillin resistance was prevalent among staphylococci with many strains demonstrating multidrug resistance. These findings may not be representative of resistance trends in community-based practices.<\/jats:p><\/jats:sec>","DOI":"10.1097\/inf.0000000000002206","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T15:33:02Z","timestamp":1538580782000},"page":"138-145","source":"Crossref","is-referenced-by-count":20,"title":["Antibiotic Resistance Among Pediatric-Sourced Ocular Pathogens: 8-Year Findings From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study"],"prefix":"10.1097","volume":"38","author":[{"given":"Sherman J.","family":"Alter","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, Dayton Children\u2019s Hospital, Wright State University Boonshoft School of Medicine, Dayton, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"Pharmaceutical Medical Affairs, Bausch + Lomb, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny A.","family":"Asbell","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleen H.","family":"DeCory","sequence":"additional","affiliation":[{"name":"Pharmaceutical Medical Affairs, Bausch + Lomb, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/ICO.0b013e31820770f4","article-title":"Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment.","volume":"30","author":"Wong","year":"2011","journal-title":"Cornea"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5301\/EJO.2011.8338","article-title":"Pediatric microbial keratitis: a tertiary hospital study.","volume":"22","author":"Song","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaapos.2012.12.151","article-title":"Trends in ophthalmic manifestations of methicillin-resistant Staphylococcus aureus (MRSA) in a northern California pediatric population.","volume":"17","author":"Amato","year":"2013","journal-title":"J AAPOS"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ajo.2014.01.013","article-title":"Pediatric microbial keratitis in Taiwan: clinical and microbiological profiles, 1998-2002 versus 2008-2012.","volume":"157","author":"Lee","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/ICU.0000000000000167","article-title":"Blepharokeratoconjunctivitis in children.","volume":"26","author":"Hammersmith","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/IOP.0000000000000472","article-title":"Pediatric acute dacryocystitis.","volume":"31","author":"Ali","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2008.04.006","article-title":"The timing of antibiotic administration in the management of infant dacryocystitis.","volume":"12","author":"Baskin","year":"2008","journal-title":"J AAPOS"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12886-017-0612-2","article-title":"Bacterial profile of ocular infections: a systematic review.","volume":"17","author":"Teweldemedhin","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1197\/j.aem.2006.08.006","article-title":"Clinical features of bacterial conjunctivitis in children.","volume":"14","author":"Patel","year":"2007","journal-title":"Acad Emerg Med"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11534380-000000000-00000","article-title":"Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.","volume":"12","author":"Comstock","year":"2010","journal-title":"Paediatr Drugs"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/AAC.44.6.1650-1654.2000","article-title":"Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).","volume":"44","author":"Block","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/01.inf.0000178066.24569.98","article-title":"Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era.","volume":"24","author":"Buznach","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11632470-000000000-00000","article-title":"Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.","volume":"32","author":"DeLeon","year":"2012","journal-title":"Clin Drug Investig"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaapos.2017.08.008","article-title":"Patient demographic and microbiology trends in bacterial conjunctivitis in children.","volume":"22","author":"Chen","year":"2018","journal-title":"J AAPOS"},{"key":"R15-20230912","first-page":"177","article-title":"A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.","volume":"1","author":"Abelson","year":"2007","journal-title":"Clin Ophthalmol"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2007.03.076","article-title":"Update on bacterial conjunctivitis in South Florida.","volume":"115","author":"Cavuoto","year":"2008","journal-title":"Ophthalmology"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/02713688109069178","article-title":"Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study.","volume":"1","author":"Cagle","year":"1981","journal-title":"Curr Eye Res"},{"issue":"suppl 4","key":"R18-20230912","first-page":"29S","article-title":"Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis.","volume":"112","author":"Leibowitz","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/OPTH.S5778","article-title":"Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.","volume":"3","author":"Bertino","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"11 suppl","key":"R20-20230912","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ophtha.2014.06.049","article-title":"Antibiotic resistance in acute postoperative endophthalmitis.","volume":"121","author":"Holland","year":"2014","journal-title":"Ophthalmology"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ICO.0000000000000352","article-title":"Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania.","volume":"34","author":"Ni","year":"2015","journal-title":"Cornea"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/0255-0857.83903","article-title":"Antibiotic resistance in ocular bacterial pathogens.","volume":"29","author":"Sharma","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","article-title":"Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.","volume":"121","author":"Gentile","year":"2014","journal-title":"Ophthalmology"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","article-title":"Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-year review.","volume":"34","author":"Chang","year":"2015","journal-title":"Cornea"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study.","volume":"152","author":"Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","article-title":"Antibiotic resistance among ocular pathogens in the united states: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study.","volume":"133","author":"Asbell","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R30-20230912","first-page":"35","article-title":"Antibiotic resistance trends among ocular pathogens in the US\u2014cumulative results from the antibiotics resistance monitoring in ocular microorganisms (ARMOR) surveillance study.","volume":"10","author":"Asbell","year":"2017","journal-title":"US Ophthalmic Rev"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference.","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies.","volume":"11","author":"Armitage","year":"1955","journal-title":"Biometrics"},{"key":"R44-20230912","first-page":"14","article-title":"Factors influencing bacterial adhesion to contact lenses.","volume":"18","author":"Dutta","year":"2012","journal-title":"Mol Vis"},{"key":"R45-20230912","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1444-0938.2002.tb03082.x","article-title":"The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa.","volume":"85","author":"Fleiszig","year":"2002","journal-title":"Clin Exp Optom"},{"key":"R46-20230912","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","article-title":"Risk factors and causative organisms in microbial keratitis.","volume":"27","author":"Green","year":"2008","journal-title":"Cornea"},{"key":"R47-20230912","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10096-017-2985-9","article-title":"Antimicrobial susceptibility of bacterial isolates from patients presenting with ear, nose and throat (ENT) infections in the German community healthcare setting.","volume":"36","author":"Olzowy","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R48-20230912","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/AAC.00966-09","article-title":"Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.","volume":"54","author":"Bae","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-20230912","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/CMR.00040-06","article-title":"Antimicrobial resistance in Haemophilus influenzae.","volume":"20","author":"Tristram","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"R50-20230912","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/meajo.MEAJO_276_16","article-title":"Update on the Epidemiology and Antibiotic Resistance of Ocular Infections.","volume":"24","author":"Miller","year":"2017","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R51-20230912","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13756-017-0185-0","article-title":"Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015.","volume":"6","author":"Oydanich","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"R52-20230912","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s10096-012-1623-9","article-title":"Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis.","volume":"31","author":"Dabernat","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R53-20230912","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12879-017-2703-3","article-title":"Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption.","volume":"17","author":"Tyrstrup","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R54-20230912","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12866-015-0350-7","article-title":"Nasopharyngeal carriage and antimicrobial susceptibility of Haemophilus influenzae among children younger than 5 years of age in Beijing, China.","volume":"15","author":"Zhu","year":"2015","journal-title":"BMC Microbiol"},{"key":"R55-20230912","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dkq127","article-title":"Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.","volume":"65","author":"Haas","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R56-20230912","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000330858","article-title":"Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin.","volume":"57","author":"Sanfilippo","year":"2011","journal-title":"Chemotherapy"},{"key":"R57-20230912","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jcrs.2008.01.016","article-title":"Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.","volume":"34","author":"Asbell","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R58-20230912","doi-asserted-by":"crossref","first-page":"e20153099","DOI":"10.1542\/peds.2015-3099","article-title":"Changing susceptibility Staphylococcus aureus of in a US pediatric population.","volume":"137","author":"Sutter","year":"2016","journal-title":"Pediatrics"},{"key":"R59-20230912","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/665010","article-title":"Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).","volume":"33","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R62-20230912","doi-asserted-by":"crossref","first-page":"e20160101","DOI":"10.1542\/peds.2016-0101","article-title":"Staphylococcus aureus infections in children: The implications of changing trends.","volume":"137","author":"Kaplan","year":"2016","journal-title":"Pediatrics"},{"key":"R63-20230912","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajo.2013.05.004","article-title":"Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?","volume":"156","author":"Fraunfelder","year":"2013","journal-title":"Am J Ophthalmol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201902000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:14:48Z","timestamp":1720656888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201902000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002206","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}